NovaBay Pharmaceuticals Inc (United States) is listed on the Nasdaq and has a market capitalization of $9.05 Millions, with shareholders equity totaling $-22.83 Millions.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, NovaBay Pharmaceuticals Inc reported $3.35 Millions in revenue, generating net income of $-5.72 Millions.
Key financial metrics include a P/E ratio of -1.58, a price-to-book (P/B) ratio of -0.40, and a trailing twelve-month dividend yield of 259.74%.
The company trades under the ticker NBY.